To many people, antioxidants are simply thought of as a good thing to consume, even if the reason why is not clear. A new study from the University of California, San Diego, shows that an overdose of antioxidants can actually inhibit the healing process.Read More
Science Market Update
Research on memory is very delicate business. The prospect of increasing memory capacity and restoring lost recollections sounds more like magic than science. Despite this, a group of researchers from the University of California, San Diego has found a way to stimulate neural networks in rats in order to erase and restore their memories.
The University of California, San Diego recently received $5.3 million in life science funding from the National Institutes of Health for the university’s Clinical and Translational Research Institute. Researchers were given notice of their new life science grant on June 7th, 2014 by the administering organization within the NIH providing the funding, the National Center for Advancing Translational Sciences. Researchers at the University of California, San Diego went into more detail on the NIH website as to how the life science funding would be used:
A neuroscience researcher at the University of California, San Diego recently received a new life science grant that will support her studies with $100,000 per year for the next three years. Dr. MJ Harbert, MD, is an assistant clinical professor in the Department of Neurosciences at UCSD. Her project, “Brain Activity During Birth for Prediction of Newborns at Risk for Brain Injury,” has gained her recognition from The Hartwell Foundation, who named her a recipient of an Individual Biomedical Research Award.
New life science research funding at the University of California, San Diego was recently awarded in the amount of $7.5 million to the Pauline and Stanley Foster Hospital for Cancer Care. The donor, Pauline Foster, is a community philanthropist who has given a great deal of support to the University of California, San Diego over the years. The Pauline and Stanley Foster Hospital for Cancer Care will encompass three floors at the Jacobs Medical Center and be home to medical staff whose purpose is caring for the complex needs of patients with cancer.
Are you a part of a research team at the University of California, San Diego and searching for ways to bring everyone in your lab together? Biotechnology Calendar, Inc.’s University of California, San Diego life science marketing event is an opportunity for everyone in your lab to spend time together in a friendly, yet professional setting while enjoying a free catered lunch. Learn about the latest life science solutions available on the market and discuss your research goals while taking a break from the lab or classroom at this upcoming life science event.
A research team at the UC San Diego’s Moores Cancer Center recently received a major new grant from the California Institute for Regenerative Medicine (CIRM) for a groundbreaking cancer study. The research will be led by Thomas J. Kipps, MD, PhD, deputy director of research operations at the Moores Cancer Center and a professor of medicine at UC San Diego (Image courtesy of UCSD).
Funded in part by grants from the California Institute for Regenerative Medicine and the NIH, researchers at the University of California, San Diego have come up with a simple, easily repeated RNA-based technique of generating human induced pluripotent stem cells (iPSCs). The study was published in the August 1st edition of Cell Stem Cell. The researchers’ method has wide-ranging applications for others searching for new cell therapies and use in other stem cell studies.
One of the reasons cancer is so successful and difficult to treat is that it uses the body's own systems to proliferate, thrive, and hide from attack. Bioresearch scientists out to target cancer are taking a similar approach, building tiny bio-vehicles for locating tumors that reach their destination without setting off a massive immune system alarm or flooding the whole body with toxic chemicals. A team of biochemists at the University of California San Diego led by Dr. Nathan Gianneschi has developed a nanoparticle that assumes a benign shape to travel covertly through the blood system, then, recognizing a tumor, reassembles via an enzymatic cue into a net to attach itself to the cancerous target.
Tags: 2014, CA, University of California San Diego, 2013, Nanobiotechnology, cancer research, Southwest, California, University of California, San Diego, SDVS, BioResearch Product Faire Event, UCSD, Biotechnology Vendor Showcase